View Older Stories View More Recent Stories

Nov 19, 2023 10:45AM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ILMN
Nov 14, 2023 04:05PM Illumina To Webcast Upcoming Investor Conferences
Nov 13, 2023 09:15AM Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries
Nov 9, 2023 04:05PM Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023
Nov 7, 2023 04:00PM Veracyte (VCYT) Announces In Vitro Diagnostic Agreement with Illumina (ILMN) to Broaden Availability of Its Tests for Patients Globally
Nov 7, 2023 04:00PM Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally
Nov 1, 2023 09:15AM Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors
Oct 13, 2023 02:10PM Illumina (ILMN) responds to European Commission's divestiture order
Oct 13, 2023 02:10PM Illumina responds to European Commission's divestiture order
Oct 11, 2023 04:05PM Illumina Posted a Stewardship-Focused Presentation for Investors
Oct 5, 2023 04:05PM Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023
Sep 5, 2023 07:30AM Illumina (ILMN) Appoints Jacob Thaysen as CEO
Sep 5, 2023 07:30AM Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer
Aug 28, 2023 04:05PM Illumina To Webcast Upcoming Investor Conference
Aug 17, 2023 09:15AM Illumina (ILMN) Announces Solutions Center in India
Aug 17, 2023 09:15AM Illumina expands genomics capabilities in India with opening of Solutions Center
Aug 11, 2023 04:05PM Illumina To Webcast Upcoming Investor Conference
Aug 9, 2023 04:15PM Illumina (ILMN) Appoints Steven Barnard as CTO
Aug 9, 2023 04:15PM Dr. Steven Barnard Appointed Chief Technology Officer
Aug 9, 2023 04:05PM Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023
Aug 1, 2023 04:05PM Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
Jul 25, 2023 09:15AM Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
Jul 18, 2023 04:05PM Illumina to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
Jul 18, 2023 09:15AM The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck
Jul 11, 2023 09:15AM Illumina (ILMN) Launches DRAGEN 4.2
Jul 11, 2023 09:15AM Illumina DRAGEN™ 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery
Jun 5, 2023 09:15AM Illumina releases 2022 Corporate Social Responsibility Report
Jun 2, 2023 07:30AM Illumina's (ILMN) Board of Directors elects two experienced Independent Directors to Board
Jun 2, 2023 07:30AM Illumina's Board of Directors elects two experienced Independent Directors to Board
Jun 1, 2023 02:01PM Illumina (ILMN) unveils AI software to predict disease-causing genetic mutations in patients
Jun 1, 2023 02:00PM Illumina unveils AI software to predict disease-causing genetic mutations in patients
May 31, 2023 04:05PM Illumina to Host Third Annual Virtual ESG Investor Event on Monday, June 12, 2023
May 30, 2023 09:15AM Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing
May 24, 2023 02:00PM Pluton Biosciences Raises $16.5M Series A led by Illumina Ventures and RA Capital to discover and deploy microbes that will fight climate change
May 16, 2023 12:00PM Illumina's genomic technologies enable better pathogen preparedness and response
May 2, 2023 09:15AM Illumina increases equitable access to STEM education, reaching over 1 million learners
Apr 25, 2023 04:30PM Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth
Apr 12, 2023 09:17AM Illumina's cloud-based informatics programs recognized for robust, international data privacy protections
Apr 11, 2023 09:16AM Illumina (ILMN) and Henry Ford Health Partner to Study Impact of Comprehensive Genomic Testing for Cardiovascular Patients
Apr 11, 2023 09:15AM Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients
Apr 5, 2023 09:15AM Illumina celebrates 25 years of innovation
Apr 4, 2023 04:05PM Illumina to Announce First Quarter 2023 Financial Results on Tuesday, April 25, 2023
Apr 4, 2023 09:19AM Illumina (ILMN) NovaSeq X exceeds 200th order milestone in first quarter 2023
Apr 4, 2023 09:15AM Illumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023
Apr 3, 2023 11:09AM Illumina (ILMN) Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024
Apr 3, 2023 11:08AM Illumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024
Mar 29, 2023 08:00AM DNA Data Storage Alliance Announces Board Appointments
Mar 27, 2023 09:15AM Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease
Mar 14, 2023 09:18AM Illumina (ILMN) launches its first product enabling long- and short-read sequencing on one instrument
Mar 14, 2023 09:15AM Illumina launches its first product enabling long- and short-read sequencing on one instrument
View More Recent Stories View Older Stories